Posted on by admin

A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder

Conditions: Bipolar I Disorder

Interventions: Drug: AL001; Drug: Lithium carbonate

Sponsors: Alzamend Neuro, Inc.; Massachusetts General Hospital

Recruiting